المؤلفون: Patel, Sandip P, Alonso-Gordoa, Teresa, Banerjee, Susana, Wang, Ding, Naidoo, Jarushka, Standifer, Nathan E, Palmer, Doug C, Cheng, Lin-Yang, Kourtesis, Panagiotis, Ascierto, Maria L, Das, Mayukh, Diamond, Jennifer R, Hellmann, Matthew D, Carneiro, Benedito A

المساهمون: AstraZeneca, Gaithersburg, MD., USA

المصدر: Journal for ImmunoTherapy of Cancer ; volume 12, issue 2, page e007340 ; ISSN 2051-1426

الإتاحة: https://doi.org/10.1136/jitc-2023-007340Test

المؤلفون: Morgan, Robert D, Clamp, Andrew R, Barnes, Bethany M, Timms, Kirsten, Schlecht, Helene, Yarram-Smith, Laura, Wallis, Yvonne, Valganon-Petrizan, Mikel, MacMahon, Suzanne, White, Rhian, Morgan, Sian, McKenna, Sarah, Hudson, Emma, Tookman, Laura, George, Angela, Manchanda, Ranjit, Sundar, Sudha S, Nicum, Shibani, Brenton, James D, Kristeleit, Rebecca S, Banerjee, Susana, McNeish, Iain A, Ledermann, Jonathan A, Taylor, Stephen S, Evans, D Gareth R, Jayson, Gordon C

المصدر: International Journal of Gynecological Cancer (2023) (In press).

مصطلحات موضوعية: BRCA1 Protein, BRCA2 Protein, Homologous recombination, Ovarian Cancer

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10169132/1/accepterd%20version%20HRD_Morgan_etal_Main%20Document_.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10169132Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10169132/1/accepterd%20version%20HRD_Morgan_etal_Main%20Document_.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10169132Test/

المؤلفون: Grisham, Rachel N, Slomovitz, Brian M, Andrews, Nicole, Banerjee, Susana, Brown, Jubilee, Carey, Mark S, Chui, Herman, Coleman, Robert L, Fader, Amanda N, Gaillard, Stephanie, Gourley, Charlie, Sood, Anil K, Monk, Bradley J, Moore, Kathleen N, Ray-Coquard, Isabelle, Shih, Ie-Ming, Westin, Shannon N, Wong, Kwong-Kwok, Gershenson, David M

المساهمون: Verastem Oncology

المصدر: International Journal of Gynecologic Cancer ; volume 33, issue 9, page 1331-1344 ; ISSN 1048-891X 1525-1438

الإتاحة: https://doi.org/10.1136/ijgc-2023-004610Test

المؤلفون: Banerjee, Susana, Stewart, James, Porta, Nuria, Toms, Christy, Leary, Alexandra, Lheureux, Stephanie, Khalique, Saira, Tai, Jeremy, Attygalle, Ayoma, Vroobel, Katherine, Lord, Christopher J, Natrajan, Rachael, Bliss, Judith

المساهمون: AstraZeneca, The Lady Garden Foundation

المصدر: International Journal of Gynecologic Cancer ; volume 31, issue 11, page 1471-1475 ; ISSN 1048-891X 1525-1438

الإتاحة: https://doi.org/10.1136/ijgc-2021-002973Test

المؤلفون: Clamp, Andrew R, Lorusso, Domenica, Oza, Amit M, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Amenedo Gancedo, Margarita, Fong, Peter C, Goh, Jeffrey C, O’Malley, David M, Armstrong, Deborah K, Banerjee, Susana, García-Donas, Jesus, Swisher, Elizabeth M, Cameron, Terri, Goble, Sandra, Coleman, Robert L, Ledermann, Jonathan A

المساهمون: Clovis Oncology

المصدر: International Journal of Gynecologic Cancer ; volume 31, issue 7, page 949-958 ; ISSN 1048-891X 1525-1438

الإتاحة: https://doi.org/10.1136/ijgc-2020-002240Test

المؤلفون: Pothuri, Bhavana, Berton, Dominique, Moreno, Victor, Oaknin, Ana, Trigo Perez, Jose Manuel, Curigliano, Giuseppe, Ellard, Susan, Pikiel, Joanna, Banerjee, Susana, Barretina-Ginesta, Maria-Pilar, Miller, Rowan, Tinker, Anna, Jewell, Andrea, Plummer, Ruth, Joly, Florence, Veneris, Jennifer, Duan, Tao, Andre, Thierry

المصدر: Journal for ImmunoTherapy of Cancer ; volume 9, issue Suppl 2, page A398-A398 ; ISSN 2051-1426

مصطلحات موضوعية: Cancer Research, Pharmacology, Oncology, Molecular Medicine, Immunology, Immunology and Allergy

الإتاحة: https://doi.org/10.1136/jitc-2021-sitc2021.370Test

المؤلفون: Gonzalez-Martin, Antonio, Harter, Philipp, Lorusso, Domenica, Moore, Kathleen N, Oaknin Benzaquen, Ana Mazaltob, Banerjee, Susana

المساهمون: Institut Català de la Salut, Banerjee S Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK. Gonzalez-Martin A Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK. Harter P Department of Gynaecology and Gynaecological Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany. Lorusso D Scientific Directorate and Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy. Moore KN Stephenson Cancer Center, University of Oklahoma, Norman, Oklahoma, USA. Oaknin A Servei d’Oncologia Mèdica, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Ovaris - Càncer -Tractament, Inhibidors enzimàtics - Ús terapèutic, DISEASES::Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Poly(ADP-ribose) Polymerase Inhibitors, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de poli(ADP-ribosa) polimerasas

وصف الملف: application/pdf

العلاقة: ESMO Open;5; https://doi.org/10.1136/esmoopen-2020-001110Test; Banerjee S, Gonzalez-Martin A, Harter P, Lorusso D, Moore KN, Oaknin A, et al. First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion. ESMO Open. 2020 Dec 11;5:e001110.; https://hdl.handle.net/11351/6331Test; 000608044000001

الإتاحة: https://doi.org/10.1136/esmoopen-2020-001110Test
https://hdl.handle.net/11351/6331Test

المؤلفون: Lorusso, Domenica, Ray-Coquard, Isabelle, Oaknin Benzaquen, Ana Mazaltob, Banerjee, Susana

المساهمون: Institut Català de la Salut, Lorusso D Scientific Directoracte and Gynecologic Oncology Unit, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Lazio, Italy. Ray-Coquard I Medical Oncology Department, Centre Leon Berard nd University Claude Bernard, Lyon, France. Oaknin A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Banerjee S MBBS MA FRCP, The Royal Marsden NHS Foundation Trust nd Institute of Cancer Research, London, UK, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Telemedicina, Pandèmia de COVID-19, 2020-, Medicina - Investigació, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, INFORMATION SCIENCE::Information Science::Communications Media::Telecommunications::Telemedicine, DISCIPLINES AND OCCUPATIONS::Natural Science Disciplines::Science::Research, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, CIENCIA DE LA INFORMACIÓN::Ciencias de la información::medios de comunicación::telecomunicaciones::telemedicina, DISCIPLINAS Y OCUPACIONES::disciplinas de las ciencias naturales::ciencia::investigación

وصف الملف: application/pdf

العلاقة: ESMO Open;5; https://doi.org/10.1136/esmoopen-2020-000924Test; Lorusso D, Ray-Coquard I, Oaknin A, Banerjee S. Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? ESMO Open. 2020 Oct 13;5:e000924.; https://hdl.handle.net/11351/6335Test; 000582759400003

الإتاحة: https://doi.org/10.1136/esmoopen-2020-000924Test
https://hdl.handle.net/11351/6335Test

المؤلفون: Stewart, James, Cunningham, Niamh, Banerjee, Susana

المصدر: International Journal of Gynecologic Cancer ; volume 33, issue 3, page 385-393 ; ISSN 1048-891X 1525-1438

الإتاحة: https://doi.org/10.1136/ijgc-2022-003704Test

المؤلفون: Morgan, Robert D, Clamp, Andrew R, Barnes, Bethany M, Timms, Kirsten, Schlecht, Helene, Yarram-Smith, Laura, Wallis, Yvonne, Valganon-Petrizan, Mikel, MacMahon, Suzanne, White, Rhian, Morgan, Sian, McKenna, Sarah, Hudson, Emma, Tookman, Laura, George, Angela, Manchanda, Ranjit, Sundar, Sudha S, Nicum, Shibani, Brenton, James D, Kristeleit, Rebecca S, Banerjee, Susana, McNeish, Iain A, Ledermann, Jonathan A, Taylor, Stephen S, Evans, D Gareth R, Jayson, Gordon C

المساهمون: AstraZeneca

المصدر: International Journal of Gynecologic Cancer ; volume 33, issue 8, page 1253-1259 ; ISSN 1048-891X 1525-1438

الإتاحة: https://doi.org/10.1136/ijgc-2022-004211Test